The C8 health project: design, methods, and participants
about
Mortality and cancer incidence in ammonium perfluorooctanoate production workersEpidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)Endocrine disrupting properties of perfluorooctanoic acidRate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West VirginiaAn overview of the effects of organic compounds on women's reproductive health and birth outcomesA critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansModeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohortsExposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plantProstate-specific antigen and perfluoroalkyl acids in the C8 health study populationBiomonitoring in California firefighters: metals and perfluorinated chemicalsCausal inference considerations for endocrine disruptor research in children's healthSerum biomarkers of polyfluoroalkyl compound exposure in young girls in Greater Cincinnati and the San Francisco Bay Area, USAAssociation of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.Perfluoroalkyl chemicals and chronic kidney disease in US adultsPerfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health ProjectThyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.Perfluorooctanoate and neuropsychological outcomes in childrenBiomarker-based calibration of retrospective exposure predictions of perfluorooctanoic acid.Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.Geocoding rural addresses in a community contaminated by PFOA: a comparison of methodsPotential Mediators between Fibromyalgia and C-Reactive protein: Results from a Large U.S. Community Survey.Perfluorooctanoate exposure and major birth defects.Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003-2006.Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation.Effect of BMI on cardiovascular and metabolic syndrome risk factors in an Appalachian pediatric populationAccumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed communityPrivate drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysisPhlebotomy treatment for elimination of perfluoroalkyl acids in a highly exposed family: a retrospective case-series.Acute Immunotoxic Effects of Perfluorononanoic Acid (PFNA) in C57BL/6 Mice.Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetryImplications of early menopause in women exposed to perfluorocarbons.Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling womenSerum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health ProjectThe mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed communityPolyfluoroalkyl compounds in Texas children from birth through 12 years of age.
P2860
Q23915929-9FF5875E-AEC9-4D29-AED3-1F2DFB04431FQ24632957-05084DC4-9A2C-40A7-9BED-36A234CB09C0Q24633469-58FE7487-EB52-472C-9DBC-D99F5E41802BQ24633826-01DEDEB9-1011-4F87-915F-C9DE60369A0AQ26155268-4C759EFF-4FEB-40C2-A8BB-496CE3977599Q28072372-FE204091-25E4-45A5-BC51-E07E38668D3CQ28383653-D3F0595A-433C-427C-9136-E2D7FE2D05EAQ28383912-F534EC4B-D6E1-4E7E-A1D4-69B302F5A1B1Q28384774-0EA44AA5-385B-4C21-81D3-141DF0140C95Q28384784-31CFDEFE-51BB-4894-B9D2-9B5EB71F005AQ28387100-3BE41EA4-A08D-41DE-BF1B-21C579469889Q28392052-29A55738-DCDB-4AEA-91D0-091C3D19D582Q28393054-AC03312B-7B81-492C-8DB6-21E0E881925EQ28393763-CEBD4E91-E1E1-4F9E-A1F9-CF10DA8C72F9Q28831121-27B21300-F4C5-4EEE-852A-F8034A0C3924Q30241400-BC7C5D73-64AB-4751-B953-28099EE3D537Q30414928-1F85919F-89F8-4A6D-BA61-5F3342CBB661Q33608031-4E315CA6-868A-4754-9A9C-D64974513331Q33654524-5A4CDC8F-4C06-4208-91B8-2EDDD1314C82Q33702676-26A78DDB-040E-40FB-B073-2528E52D395EQ33843051-90AE709E-97F5-4762-BDD0-D7121F812246Q33882623-45DCD285-48C5-4CCF-AF53-79B82FBD38BEQ33984406-06F4ABF1-8961-4462-A0DC-1FBCABA20C31Q34074733-514E45EF-CB73-479A-800E-7FE899BEE09AQ34273620-E0DD0592-FD0B-4EF7-8FA1-1BC78C559D4FQ34273663-933042DF-2172-42F5-873D-F7E31C902499Q34478458-D3473CE9-4BB0-4D1A-A7C7-EF6BD03F1681Q34478572-477182FD-424B-44C3-87BF-A846E9B41DB6Q34647222-BBDC9484-EACC-4094-AFDF-A943499435F1Q34689412-DD4E4C15-0EE0-4DD2-B5BB-FBA46E31C4E7Q34813325-60E1CC54-2B60-4F07-84DA-0AC165F29801Q35049761-CBA9D4EB-26F3-467A-8E51-CEF9E9927FE5Q35127685-F12FE036-FE72-4D16-AC8F-0DEBE802FC95Q35504523-0574C72A-4F91-470B-8334-5877E9969AFEQ35562877-20BC64B2-78E6-43E7-AD10-1593A32C2E17Q35591930-4F31B5F8-569C-4726-9DC7-AD51D1421577Q35682907-EDE607AB-25D7-4F63-9E7F-C33BED1D076AQ35732800-49840483-6294-422F-80CC-9B3F60EE8FBBQ35874820-8FADD8DF-5B83-4360-8984-B7C34C55560DQ35920263-ED5886E5-83EF-4CBA-8E64-1BF474386E10
P2860
The C8 health project: design, methods, and participants
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The C8 health project: design, methods, and participants
@ast
The C8 health project: design, methods, and participants
@en
The C8 health project: design, methods, and participants
@nl
type
label
The C8 health project: design, methods, and participants
@ast
The C8 health project: design, methods, and participants
@en
The C8 health project: design, methods, and participants
@nl
prefLabel
The C8 health project: design, methods, and participants
@ast
The C8 health project: design, methods, and participants
@en
The C8 health project: design, methods, and participants
@nl
P2093
P2860
P356
P1476
The C8 health project: design, methods, and participants
@en
P2093
A Paul Brooks
Alan M Ducatman
Anoop Shankar
Arthur Maher
Cecil Pollard
Chuanfang Jin
Joel A Halverson
Kevin M Leyden
Patsy Flensborg
Sarah S Knox
P2860
P304
P356
10.1289/EHP.0800379
P407
P577
2009-12-01T00:00:00Z